Filtered By:
Therapy: Corticosteroid Therapy
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 3967 results found since Jan 2013.
The Effect of Corticosteroids on Sinus Microbiota in Chronic Rhinosinusitis Patients with Nasal Polyposis
CONCLUSION: In this pilot study, both treatment options were effective to improve symptoms in the short-term but not in the long-term, and were not linked to any clear sinus microbiota response. As a result, this study supports the avoidance of systemic antibiotics without evidence of active infection.PMID:37475202 | DOI:10.1177/19458924231183848
Source: American Journal of Rhinology and Allergy - July 21, 2023 Category: ENT & OMF Authors: Yousif Alammar Simon Rousseau Martin Desrosiers Marc A Tewfik Source Type: research
“Intramuscular corticosteroid injections should be an option under the policy level recommendation in the International Consensus Statement on Allergic Rhinitis”
Source: International Forum of Allergy and Rhinology - July 21, 2023 Category: Allergy & Immunology Authors: Sarah K. Wise,
Fuad Baroody Tags: RESPONSE TO LETTER TO THE EDITOR Source Type: research
Real ‐world effectiveness of mepolizumab in severe asthma and chronic rhinosinusitis in the United States: impact of comorbidity and sinus surgery
ConclusionsConsistent with trial data, mepolizumab use in real-world practice shows benefits across comorbid patient cohorts with more a pronounced impact in those with severe asthma+comorbid CRS + sinus surgery.
Source: International Forum of Allergy and Rhinology - July 20, 2023 Category: Allergy & Immunology Authors: Jared Silver,
Arijita Deb,
Fran çois Laliberté,
Chi Gao,
Neil Bhattacharyya Tags: ORIGINAL ARTICLE Source Type: research
Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents ’ efficacy
ConclusionsAlthough the present analysis showed a moderate supremacy of dupilumab, there is still no evidence-based answer to the question “which biologic agent is the most effective in CRS treatment?” Improved statistical methodology, head-to-head trials, and real-life studies could lead to more robust conclusions, establishing the real role of the specific biologic agents.
Source: International Forum of Allergy and Rhinology - July 19, 2023 Category: Allergy & Immunology Authors: Georgios X. Papacharalampous,
Jannis Constantinidis,
George Fotiadis,
Nan Zhang,
Claus Bachert,
Michael Katotomichelakis Tags: REVIEW ARTICLE Source Type: research
Long ‐term treatment outcomes in refractory rhinitis medicamentosa managed with nasal surgery
ConclusionSurgically re-establishing a nasal airway was associated with long-term decongestant cessation and symptom improvement in medically refractory RM.This article is protected by copyright. All rights reserved
Source: International Forum of Allergy and Rhinology - July 15, 2023 Category: Allergy & Immunology Authors: William Li,
Shibalik Misra,
Richard John Harvey,
Larry Kalish Tags: ORIGINAL ARTICLE Source Type: research
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study)
ConclusionWe did not find substantial evidence of an increased risk of HSR due to the absence of H2A in the premedication protocols for paclitaxel. Thus, in contrary to the existing literature on paclitaxel, our findings support the use of a premedication protocol without H2A.
Source: European Journal of Clinical Pharmacology - July 13, 2023 Category: Drugs & Pharmacology Source Type: research
From the Pages of AllergyWatch
For this edition of From the Pages of AllergyWatch, I've chosen articles from recent issues of AllergyWatch. The first article, with comments from Dr. Oppenheimer, presents data from a Dutch database analyzing corticosteroid use in asthma. The next article, with comments from Dr. Chipps, also investigates the use of oral corticosteroids assessing morbidity in asthma patients. The third article, with comments from Dr. Joshi, investigated the timing of peanut introduction in Australian children.
Source: Annals of Allergy, Asthma and Immunology - July 13, 2023 Category: Allergy & Immunology Authors: Stanley M. Fineman, John J. Oppenheimer, Bradley E. Chipps, Shyam R. Joshi Tags: Special Series Source Type: research
Prevalence of atopic dermatitis in the adolescent population of Catalonia (Spain)
CONCLUSIONS: This is the first Spanish study reporting the overall diagnosed prevalence for a large-scale adolescent cohort (12-17 years old) from Catalonia. It provides new and robust evidence of AD's prevalence and related characteristics in this region.PMID:37422786 | DOI:10.15586/aei.v51i4.893
Source: Allergologia et Immunopathologia - July 9, 2023 Category: Allergy & Immunology Authors: Toni Mora Irene S ánchez-Collado Joaquim Mullol Rosa Mu ñoz-Cano Paula Rib ó Antonio Valero Source Type: research
